Ketamine's secret: family history of alcoholism may boost antidepressant effects
NCT ID NCT02122562
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study explores why ketamine, a fast-acting antidepressant, works better in people with a family history of alcohol use disorder. Researchers will give a single low-dose ketamine infusion to 60 adults with treatment-resistant depression while scanning their brains with powerful 7T MRI. They aim to measure changes in brain chemistry and connectivity to understand the biological reasons behind the enhanced response.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ketamine
- What this could lead to
- If successful, this could help doctors personalize depression treatment by identifying who will benefit most from ketamine.
- What could go wrong
- This is a small, early-phase study (60 people) focused on understanding mechanisms, not proving effectiveness. Results may not apply to all depression patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Iowa Health Care
RECRUITINGIowa City, Iowa, 52242, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A closer look: could hysteroscopy guide better repair of cesarean scar defects?
- Can brain scans and gut bacteria reveal Alzheimer's secrets?
- Zapping the brain to fight alcoholism: a new hope?
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Can a new MRI scan reveal hidden tumor weaknesses?
- Brain scans may guide psychedelics and magnetic pulses to quell suicidal thoughts